Sunitinib therapy as a cause of diffuse digestive tract hemorrhage in end-stage renal disease patient.
作者信息
Taki Yasuhiro, Imai Naohiko, Kojima Shigeki, Kaneshiro Nagayuki, Shibagaki Yugo
机构信息
Department of Internal Medicine, Division of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
出版信息
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):483-484. doi: 10.4103/1319-2442.229278.
PMID:29657229
Abstract
摘要
相似文献
1
Sunitinib therapy as a cause of diffuse digestive tract hemorrhage in end-stage renal disease patient.
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):483-484. doi: 10.4103/1319-2442.229278.
2
The US Food and Drug Administration's Approval of Adjuvant Sunitinib for Renal Cell Cancer: A Case of Regulatory Capture?
JAMA Oncol. 2018 May 1;4(5):623-624. doi: 10.1001/jamaoncol.2017.5697.
3
Kidney cancer: Intermittent sunitinib is an effective renal carcinoma treatment.
Nat Rev Urol. 2017 May;14(5):264-266. doi: 10.1038/nrurol.2017.36. Epub 2017 Mar 7.
4
Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study.
Cancer Commun (Lond). 2019 Oct 11;39(1):56. doi: 10.1186/s40880-019-0405-5.
5
Nonthrombocytopenic, noninflammatory simplex purpura during sunitinib therapy.
Int J Dermatol. 2019 Aug;58(8):e153-e155. doi: 10.1111/ijd.14458. Epub 2019 Apr 8.
6
Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
Anticancer Drugs. 2009 Oct;20(9):848-9. doi: 10.1097/CAD.0b013e32832fffc7.
7
Hepatitis D reactivation in a patient with metastatic renal cell carcinoma receiving sunitinib therapy.
Tumori. 2019 Dec;105(6):NP72-NP74. doi: 10.1177/0300891619840279. Epub 2019 Apr 1.
8
Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysis.
Future Oncol. 2019 Jun;15(18):2175-2190. doi: 10.2217/fon-2018-0858. Epub 2019 Apr 23.
9
Understanding the adverse event experience in the S-TRAC adjuvant trial of sunitinib for high-risk renal cell carcinoma.
Future Oncol. 2020 Feb;16(4):39-47. doi: 10.2217/fon-2019-0369. Epub 2020 Jan 10.
10
Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma on Sunitinib.
Indian J Cancer. 2016 Jan-Mar;53(1):112-3. doi: 10.4103/0019-509X.180852.
Zotero 插件